CenterBook Partners’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13M Buy
113,720
+10,569
+10% +$1.24M 0.6% 33
2026
Q2
$11M Buy
103,151
+67,919
+193% +$8.22M 0.54% 33
2026
Q1
$5.76M Buy
+35,232
New +$5.42M 0.31% 90
2025
Q2
– Sell
-15,991
Closed -$1.22M – 551
2025
Q1
$1.22M Buy
15,991
+6,600
+70% +$505K 0.08% 285
2024
Q4
$648K Sell
9,391
-71,945
-88% -$5.18M 0.04% 389
2024
Q3
$5.94M Buy
+81,336
New +$6M 0.37% 82

Other funds holding INSM

CenterBook Partners's INSM Position: Q3 2026 in Review

CenterBook Partners increased its Insmed (INSM) stake by 10% in Q3 2026, buying an estimated $1.24M and bringing the position to 113,720 shares worth $13M. The position accounts for 0.6% of the portfolio, ranked #33.

CenterBook Partners first reported a position in INSM in Q3 2024 and has held it in 6 quarters since. 219 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • CenterBook Partners held 113,720 shares of Insmed worth $13M as of Q3 2026.
  • CenterBook Partners bought 10,569 Insmed shares in Q3 2026, an estimated $1.24M.
  • Insmed made up 0.6% of CenterBook Partners's portfolio in Q3 2026, its #33 holding.
  • CenterBook Partners first reported a position in Insmed in Q3 2024 and has held it in 6 quarters since.
  • 219 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.